Bornheim L M, Parish D W, Smith K M, Litman D A, Correia M A
Arch Biochem Biophys. 1986 Apr;246(1):63-74. doi: 10.1016/0003-9861(86)90449-2.
The relative potential of various structural isomers (III, XIII) and various 2,4-side chain modified analogs of heme (iron-protoporphyrin IX) to incorporate into rat liver hemoproteins, cytochrome P-450(s), and tryptophan pyrrolase was examined. Such assessments for hepatic cytochrome P-450 relied on generation of reconstitutible apocytochrome(s) P-450 by suicidal alkylation of the existing prosthetic heme moiety by allylisopropylacetamide (AIA) in vivo. Subsequent replacement of the prosthetic heme was brought about by incubating the apocytochrome(s) P-450-enriched preparations with a particular heme isomer or analog. Structure-function relationships of the reconstituted isozymes were assessed in microsomal preparations by monitoring cytochrome P-450 content (structure) and its mixed function oxidase activity (function). In parallel, the relative ability of these heme isomers and analogs to functionally constitute hepatic tryptophan pyrrolase was also assessed by monitoring the relative increase in holoenzyme activity when preparations deliberately enriched in constitutible apoenzyme were incubated with each of these compounds. The findings reveal that 2,4-side chain modifications on the heme IX skeleton markedly influence the function of the constituted hemoproteins possibly by affecting their structural assembly through steric, electronic, and/or hydrophobic interactions with the corresponding apoproteins. Furthermore, these studies not only reveal that the structural specifications of the active prosthetic site of rat liver cytochrome P-450(s) differ from those of tryptophan pyrrolase, but also that the structural specifications of these mammalian hemoproteins for their prosthetic heme differ considerably from those reported for their bacterial counterparts.
研究了各种结构异构体(III、XIII)以及血红素(铁原卟啉IX)的各种2,4-侧链修饰类似物掺入大鼠肝脏血红素蛋白、细胞色素P-450和色氨酸吡咯酶的相对潜力。对肝细胞色素P-450的此类评估依赖于通过体内烯丙基异丙基乙酰胺(AIA)对现有辅基血红素部分进行自杀性烷基化来生成可重组的脱辅基细胞色素P-450。随后,通过将富含脱辅基细胞色素P-450的制剂与特定的血红素异构体或类似物一起孵育来实现辅基血红素的替换。通过监测细胞色素P-450含量(结构)及其混合功能氧化酶活性(功能),在微粒体制剂中评估重组同工酶的结构-功能关系。同时,通过监测当故意富含可组成的脱辅基酶的制剂与这些化合物中的每一种一起孵育时全酶活性的相对增加,也评估了这些血红素异构体和类似物在功能上构成肝脏色氨酸吡咯酶的相对能力。研究结果表明,血红素IX骨架上的2,4-侧链修饰可能通过与相应脱辅基蛋白的空间、电子和/或疏水相互作用影响其结构组装,从而显著影响所构成的血红素蛋白的功能。此外,这些研究不仅揭示了大鼠肝脏细胞色素P-450活性辅基位点的结构规范与色氨酸吡咯酶的不同,还表明这些哺乳动物血红素蛋白对其辅基血红素的结构规范与报道的细菌对应物有很大差异。